Sharda Cropchem

SHARDACROP · NSE

— · —

₹721.45

Closing price — 29 Sept 2026

Market cap ₹6,464 Cr · EPS ₹78.42

Valuation

Blended fair value using DCF and peer comparison methods.

See if Sharda Cropchem is undervalued

Unlock intrinsic value for 4,800+ Indian stocks — free.

The intrinsic value shown is an algorithmic estimate based on publicly available financial data — including DCF analysis, peer comparison, and historical financials. It is not a research report, investment advice, or a recommendation to buy, sell, or hold any security. Stock valuations involve uncertainty and may differ significantly from market prices. Please consult a SEBI-registered investment adviser before making any investment decision.

Peer comparison

How this company stacks up against sector peers on valuation and quality metrics.

Chemicals · 8 peers · sector medians shown

Better than medianWorse than median

Company	Mkt Cap	P/E	P/B	EV/EBITDA	ROE	Net Margin	Rev CAGR 3y
Sharda Cropchem SHARDACROP · you	₹6,646 Cr	9.4×	3.2×	—	33.4%	0.1%	—
Sector median	—	43.0×	6.0×	30.2×	14.7%	1.6%	3.1%
BASF India Limited BASF	₹16,665 Cr	43.0×	4.5×	22.3×	10.6%	2.8%	3.1%
Fine Organic Industries Limited FINEORG	₹16,217 Cr	38.3×	6.0×	30.2×	15.7%	17.6%	-7.8%
Vinati Organics Limited VINATIORGA	₹13,837 Cr	27.8×	5.4×	—	19.3%	0.2%	—
Privi Speciality Chemicals Limited PRIVISCL	₹13,608 Cr	36.5×	13.7×	—	37.6%	0.1%	—
Sudeep Pharma Limited SUDEEPPHRM	₹12,509 Cr	107.6×	—	—	—	0.3%	—
Alkyl Amines Chemicals Limited ALKYLAMINE	₹10,444 Cr	54.7×	6.4×	35.8×	11.7%	11.7%	-3.0%
Elantas Beck India Limited ELANTAS	₹9,065 Cr	61.8×	9.1×	48.4×	14.7%	17.4%	9.6%
Sudarshan Chemical Industries Limited SUDARSCHEM	₹8,698 Cr	314.9×	2.0×	19.0×	0.7%	0.2%	62.0%

Peer comparison verdict

Sharda looks attractively valued — trading at a discount to sector peers on P/E (9.2× vs sector median 43.0×) while delivering above-average returns on equity (33.4% vs 14.7%).

Business quality

Valuation

P/E ratio

9.2×

P/B ratio

—

EV/EBITDA

—

Price/Sales

—

Returns

ROE

33.4%

ROCE

—

ROA

—

Growth

Revenue CAGR (3yr)

—

EPS CAGR (3yr)

—

Efficiency

Asset turnover

—

FCF yield

—

Dividend yield

—

Liquidity & Solvency

Debt / Equity

—

Debt / EBITDA

—

Interest coverage

—

Current ratio

—

Quick ratio

—

Financial health

Piotroski F-Score, Altman Z-Score, and key solvency ratios.

Financial health data is not yet available for this company.

Full financial data

Charts and annual statements for income, balance sheet and cash flow.

Income trend

Revenue, profit and margin trends over time.

Income statement data is unavailable for this company.

Cash flow

Where cash comes from and where it goes.

Cash flow data is not yet available for this company.

Balance sheet

Assets show what the company owns. Liabilities show what it owes. Equity is what's left for shareholders.

Balance sheet data is not yet available for this company.

Numbers are illustrative — order-of-magnitude correct. For precise figures, refer to the company's annual report on BSE/NSE.

Shareholding pattern

Who owns this company and how that has changed.

Shareholding data is not yet available for this company.